The Journal of Korean Diabetes

Opinion
Approach to Fatty Liver Disease in Patients with Type 2 Diabetes: Ji Cheol Bae; J Korean Diabetes. 2023;24(3):107-110.

Type 2 diabetes is a major risk factor for development and progression of non-alcoholic fatty liver disease (NAFLD). Fatty liver is prevalent in people with type 2 diabetes, and overweight...

Statement
Management of Dyslipidemia in Patients with Diabetes Mellitus: Kyung Ae Lee; J Korean Diabetes. 2023;24(3):111-119.

Most patients with diabetes mellitus (DM) have dyslipidemia, which is characterized by increased triglycerides, decreased high-density lipoprotein cholesterol, and increased small dense low-density lipoprotein cholesterol (LDL-C). Dyslipidemia is an important...

Focused Issue
2023 Clinical Practice Guidelines for Diabetes: Min Kyong Moon; J Korean Diabetes. 2023;24(3):120-126.

The Committee on Clinical Practice Guidelines of the Korean Diabetes Association updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the eighth edition in...

Focused Issue
2023 Clinical Practice Guidelines for Diabetes: Recommendations for Pharmacological Treatment of Type 2 Diabetes: Junghyun Noh; J Korean Diabetes. 2023;24(3):127-134.

The 2023 clinical practice guidelines for diabetes in Korea are reviewed and updated biennially by the Committee of Clinical Practice Guidelines of the Korean Diabetes Association based on the latest...

Focused Issue
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors: Ye Seul Yang; J Korean Diabetes. 2023;24(3):135-140.

To prevent cardiovascular disease (CVD), which is one of the ultimate goals in the management of patients with diabetes, it is important to control not only hyperglycemia, but also modifiable...

Focused Issue
2023 Clinical Practice Guidelines for Diabetes: Continuous Glucose Monitoring and Insulin Pumps: Sang-Man Jin; J Korean Diabetes. 2023;24(3):141-147.

With the expanding use of continuous glucose monitoring (CGM) and insulin pumps worldwide, several international guidelines dedicated to diabetes technology have been developed. Recently, the Korean Diabetes Association released a...

Information Desk
Characteristics of the Latest Therapeutic Agent for Diabetes: Nuri Yun; J Korean Diabetes. 2023;24(3):148-153.

The latest therapeutic agent for diabetes is characterized by a longer lasting blood glucose control effect than existing treatments and stable blood glucose control. In addition, it has the advantage...

Information Desk
Diabetes and Dietary Fats: Jae Won Cho; J Korean Diabetes. 2023;24(3):154-163.

Fats are important nutrients that supply energy and help to regulate the processes of the human body. The proportion of fat in the energy intake of Koreans, as well as...

Information Desk
Trends and Effects in Evidence-Based Psycho-Social Interventions for Patients with Diabetes: Jung-won Lim; J Korean Diabetes. 2023;24(3):164-171.

The purpose of this study is to explore psycho-social interventions for patients with diabetes and to suggest the effects of such interventions based on findings from systematic review and meta-analysis....

Current Issue: Volume 24(3); Sep 2023

Opinion

Approach to Fatty Liver Disease in Patients with Type 2 Diabetes: Ji Cheol Bae; J Korean Diabetes. 2023;24(3):107-110. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.107

Statement

Management of Dyslipidemia in Patients with Diabetes Mellitus: Kyung Ae Lee; J Korean Diabetes. 2023;24(3):111-119. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.111

Focused Issues

2023 Clinical Practice Guidelines for Diabetes: Min Kyong Moon; J Korean Diabetes. 2023;24(3):120-126. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.120

2023 Clinical Practice Guidelines for Diabetes: Recommendations for Pharmacological Treatment of Type 2 Diabetes: Junghyun Noh; J Korean Diabetes. 2023;24(3):127-134. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.127

2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors: Ye Seul Yang; J Korean Diabetes. 2023;24(3):135-140. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.135

2023 Clinical Practice Guidelines for Diabetes: Continuous Glucose Monitoring and Insulin Pumps: Sang-Man Jin; J Korean Diabetes. 2023;24(3):141-147. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.141

Information Desks

Characteristics of the Latest Therapeutic Agent for Diabetes: Nuri Yun; J Korean Diabetes. 2023;24(3):148-153. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.148

Diabetes and Dietary Fats: Jae Won Cho; J Korean Diabetes. 2023;24(3):154-163. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.154

Trends and Effects in Evidence-Based Psycho-Social Interventions for Patients with Diabetes: Jung-won Lim; J Korean Diabetes. 2023;24(3):164-171. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.164

Volume 24, No. 3

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

3,496	Recent Advances in Anti-Obesity Drugs
1,529	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
2,838	Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management
2,966	Glycemic Variability and Diabetes Mellitus
3,655	A Position Statement of the Utilization and Support Status of Continuous Glucose Monitoring in Korea

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2023 by Korean Diabetes Association. All rights reserved.

prev

next